Bank of New York Mellon Corp - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 197 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.15 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$12,504,000
-10.9%
1,005,186
-2.0%
0.00%0.0%
Q3 2016$14,038,000
+83.4%
1,025,365
-1.0%
0.00%
+100.0%
Q2 2016$7,655,000
+39.8%
1,035,881
+20.9%
0.00%0.0%
Q1 2016$5,477,000
+0.9%
857,131
-1.3%
0.00%0.0%
Q4 2015$5,429,000
+5.1%
868,720
-1.8%
0.00%0.0%
Q3 2015$5,166,000
-38.9%
884,684
-13.5%
0.00%0.0%
Q2 2015$8,459,000
+6.4%
1,022,905
+6.0%
0.00%0.0%
Q1 2015$7,953,000
+23.8%
965,276
+3.2%
0.00%0.0%
Q4 2014$6,426,000
+26.5%
935,352
-0.5%
0.00%
+100.0%
Q3 2014$5,078,000
-59.6%
940,410
-52.4%
0.00%
-50.0%
Q2 2014$12,576,000
+116.2%
1,974,086
+173.6%
0.00%0.0%
Q1 2014$5,816,000
+19.5%
721,605
+1.1%
0.00%
+100.0%
Q4 2013$4,867,000
-83.5%
713,716
-55.4%
0.00%
-75.0%
Q3 2013$29,468,000
+101.5%
1,601,544
+91.6%
0.00%
-20.0%
Q2 2013$14,623,000836,0490.01%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$82,111,00018.09%
Consonance Capital Management LP 5,575,742$35,629,0005.39%
Opaleye Management Inc. 1,250,000$7,988,0004.98%
Tamarack Advisers, LP 1,600,000$10,224,0003.58%
Camber Capital Management LP 5,405,235$34,539,0002.02%
IRONWOOD INVESTMENT MANAGEMENT LLC 324,636$2,074,0001.36%
Palo Alto Investors LP 2,248,317$14,367,0001.12%
1492 Capital Management LLC 202,500$1,294,0001.09%
Geduld E E 120,100$767,0001.05%
JS Capital Management LLC 868,700$5,551,0001.00%
View complete list of ARIAD PHARMACEUTICALS INC shareholders